{"id":"https://openalex.org/W7127047293","doi":"https://doi.org/10.1016/j.jfma.2026.01.064","title":"Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies","display_name":"Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies","publication_year":2026,"publication_date":"2026-02-01","ids":{"openalex":"https://openalex.org/W7127047293","doi":"https://doi.org/10.1016/j.jfma.2026.01.064","pmid":"https://pubmed.ncbi.nlm.nih.gov/41629177"},"language":"en","primary_location":{"id":"doi:10.1016/j.jfma.2026.01.064","doi":"https://doi.org/10.1016/j.jfma.2026.01.064","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jfma.2026.01.064","pdf_url":null,"source":{"id":"https://openalex.org/S2755764997","display_name":"Journal of the Formosan Medical Association","issn_l":"0929-6646","issn":["0929-6646","1876-0821"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.jfma.2026.01.064","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072593323","display_name":"Chun\u2010Jen Liu","orcid":"https://orcid.org/0000-0002-6202-0993","observed_orcids":["https://orcid.org/0000-0002-6202-0993"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Chun-Jen Liu","raw_affiliation_strings":["National Taiwan University Hospital, Taiwan. Electronic address: cjliu@ntu.edu.tw"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taiwan. Electronic address: cjliu@ntu.edu.tw","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124698092","display_name":"Hsin-Jung Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hsin-Jung Lin","raw_affiliation_strings":["Gilead Sciences, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124696603","display_name":"David Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Lin","raw_affiliation_strings":["Gilead Sciences, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111226817","display_name":"Kyung min Kwon","orcid":"https://orcid.org/0000-0002-6298-8507","observed_orcids":["https://orcid.org/0000-0002-6298-8507"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyung min Kwon","raw_affiliation_strings":["Gilead Sciences, United States"],"raw_orcid":"https://orcid.org/0000-0002-6298-8507","affiliations":[{"raw_affiliation_string":"Gilead Sciences, United States","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5124742330","display_name":"Linda Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Chen","raw_affiliation_strings":["Gilead Sciences, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, United States","institution_ids":["https://openalex.org/I4210140816"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072593323"],"corresponding_institution_ids":["https://openalex.org/I4210131804"],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":{"value":1500,"currency":"USD","value_usd":1500},"fwci":7.8917,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.95964387,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.949999988079071},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.9900000095367432},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7689999938011169},{"id":"https://openalex.org/keywords/baseline-assessment","display_name":"baseline assessment","score":0.5989999771118164},{"id":"https://openalex.org/keywords/treatment-monitoring","display_name":"treatment monitoring","score":0.460999995470047},{"id":"https://openalex.org/keywords/case-managers","display_name":"case managers","score":0.5220000147819519},{"id":"https://openalex.org/keywords/physician-attitudes","display_name":"physician attitudes","score":0.6679999828338623},{"id":"https://openalex.org/keywords/patient-reported-barriers","display_name":"patient-reported barriers","score":0.47600001096725464},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6259999871253967},{"id":"https://openalex.org/keywords/telemedicine","display_name":"telemedicine","score":0.7400000095367432},{"id":"https://openalex.org/keywords/national-health-insurance","display_name":"national health insurance","score":0.6589999794960022},{"id":"https://openalex.org/keywords/taiwan","display_name":"Taiwan","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9854000210762024},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.7160000205039978},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5432000160217285},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.5339999794960022},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5320000052452087},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.37709999084472656},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.36000001430511475},{"id":"https://openalex.org/C3020505244","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral treatment","level":4,"score":0.34470000863075256},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3440000116825104},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.32510000467300415},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3246999979019165},{"id":"https://openalex.org/C2993512173","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral therapy","level":4,"score":0.32190001010894775},{"id":"https://openalex.org/C2779891985","wikidata":"https://www.wikidata.org/wiki/Q46994","display_name":"Telemedicine","level":3,"score":0.32010000944137573},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.25929999351501465},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jfma.2026.01.064","doi":"https://doi.org/10.1016/j.jfma.2026.01.064","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jfma.2026.01.064","pdf_url":null,"source":{"id":"https://openalex.org/S2755764997","display_name":"Journal of the Formosan Medical Association","issn_l":"0929-6646","issn":["0929-6646","1876-0821"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association","raw_type":"journal-article"},{"id":"pmid:41629177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41629177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association = Taiwan yi zhi","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jfma.2026.01.064","doi":"https://doi.org/10.1016/j.jfma.2026.01.064","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jfma.2026.01.064","pdf_url":null,"source":{"id":"https://openalex.org/S2755764997","display_name":"Journal of the Formosan Medical Association","issn_l":"0929-6646","issn":["0929-6646","1876-0821"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2042702201","https://openalex.org/W2981441783","https://openalex.org/W3066926612","https://openalex.org/W3094347363","https://openalex.org/W3133542224","https://openalex.org/W3144477401","https://openalex.org/W4200036165","https://openalex.org/W4200219817","https://openalex.org/W4205638443","https://openalex.org/W4294597669","https://openalex.org/W4377138640","https://openalex.org/W4385603279"],"related_works":[],"abstract_inverted_index":{"OBJECTIVES:":[0],"In":[1],"Taiwan,":[2],"comprehensive":[3],"pretreatment":[4],"assessments":[5],"and":[6,49,80,96,121,141,145,156,179,192,223,231],"laboratory":[7],"monitoring":[8],"visits":[9],"are":[10],"required":[11],"for":[12,167,174,215],"patients":[13,118,208],"receiving":[14],"National":[15],"Health":[16],"Insurance":[17],"Administration-reimbursed":[18],"direct-acting":[19],"antiviral":[20],"(DAA)":[21],"treatment,":[22,120],"with":[23],"results":[24],"reported":[25,185],"via":[26,85],"the":[27,51,199],"virtual":[28],"private":[29],"network":[30],"(VPN)":[31],"registration":[32],"system.":[33],"The":[34,169],"study":[35,62],"aims":[36],"to":[37,68,102],"gather":[38],"opinions":[39],"on":[40,209],"a":[41,86,103],"simplified":[42,104],"DAA":[43,105],"treatment":[44,55,106,137,157,211,229],"strategy,":[45],"assess":[46],"its":[47],"feasibility,":[48],"understand":[50],"burden":[52,230],"of":[53,74,117,177,182,190,195],"HCV":[54,76,210],"adherence.":[56,217],"METHODS:":[57],"A":[58,72],"non-interventional":[59],"prospective":[60],"survey":[61],"was":[63],"conducted":[64],"from":[65],"October":[66],"17":[67],"December":[69],"20,":[70],"2022.":[71],"total":[73],"100":[75],"patients,":[77],"50":[78,161],"physicians,":[79],"20":[81],"case":[82,146,183,196],"managers":[83,147,197],"participated":[84],"hybrid":[87],"survey.":[88],"Patients":[89],"were":[90,112],"grouped":[91],"into":[92],"comorbidity,":[93],"special":[94],"populations,":[95],"others":[97],"(3:1:1).":[98],"Factors":[99],"influencing":[100],"adherence":[101],"strategy":[107],"versus":[108],"current":[109],"NHIA":[110],"requirements":[111,222],"analyzed.":[113],"RESULTS:":[114],"Fifteen":[115],"percent":[116],"declined":[119],"15":[122],"%":[123,176,181,189,194],"experienced":[124],"interruptions.":[125],"Key":[126],"barriers":[127],"included":[128],"low":[129],"perceived":[130],"disease":[131],"severity":[132],"(47":[133],"%),":[134],"concerns":[135],"about":[136],"effectiveness":[138],"(40":[139],"%)":[140,155,162],"logistical":[142],"challenges.":[143],"Physician":[144],"cited":[148],"poor":[149],"physical":[150],"performance":[151],"(46":[152],"%,":[153,160],"55":[154],"intolerance":[158],"(42":[159],"as":[163],"major":[164],"medical":[165],"reasons":[166],"discontinuation.":[168],"COVID-19":[170],"pandemic":[171],"disrupted":[172],"care":[173],"16":[175],"physician-reported":[178],"35":[180],"manager":[184],"cases.":[186],"Additionally,":[187],"58":[188],"physicians":[191],"40":[193],"found":[198],"VPN":[200,221],"system":[201],"overly":[202],"complex":[203],"or":[204],"unnecessary.":[205],"CONCLUSIONS:":[206],"Educating":[207],"benefits":[212],"is":[213],"crucial":[214],"improving":[216],"Individualized":[218],"monitoring,":[219],"streamlined":[220],"expanded":[224],"telemedicine":[225],"use":[226],"may":[227],"reduce":[228],"enhance":[232],"long-term":[233],"success.":[234]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-02-03T00:00:00"}